Your browser doesn't support javascript.
loading
Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients.
Chen, Xiutian; Wang, Jiali; Lin, Yongda; Yao, Kaijin; Xie, Yina; Zhou, Tianbiao.
Affiliation
  • Chen X; Department of Nephrology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Wang J; Department of Nephrology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Lin Y; Department of Nephrology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Yao K; Department of Nephrology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Xie Y; Department of Nephrology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Zhou T; Department of Nephrology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Front Endocrinol (Lausanne) ; 14: 1236404, 2023.
Article in En | MEDLINE | ID: mdl-38047108

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic / Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Type of study: Systematic_reviews Limits: Humans Country/Region as subject: America do norte Language: En Journal: Front Endocrinol (Lausanne) Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic / Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Type of study: Systematic_reviews Limits: Humans Country/Region as subject: America do norte Language: En Journal: Front Endocrinol (Lausanne) Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland